83 results
Page 3 of 5
8-K
EX-99.1
emgyxfan
1 Mar 22
Crinetics Pharmaceuticals Expands Executive Team with Appointment of James Hassard as Chief Commercial Officer
8:00am
8-K
t8iwiz6ax05
1 Mar 22
Crinetics Pharmaceuticals Expands Executive Team with Appointment of James Hassard as Chief Commercial Officer
8:00am
8-K
EX-99.1
fj1ywfejcrsmj9
5 Jan 22
Departure of Directors or Certain Officers
5:00pm
424B5
ez15wg5zuzrj8gy
21 Oct 21
Prospectus supplement for primary offering
4:26pm
8-K
EX-1.1
fpo6fi ri1hat
21 Oct 21
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
4:24pm
424B5
kron2myfnv
20 Oct 21
Prospectus supplement for primary offering
4:15pm
S-3ASR
n8dh2nfoetu
10 Aug 21
Automatic shelf registration
5:25pm
8-K
EX-99.1
g5ozkvskquwcrt
29 Jul 21
Stock Purchase Agreement
4:15pm
DEFA14A
9q5wv1b
30 Apr 21
Additional proxy soliciting materials
12:00am
8-K
EX-1.1
c7ihwo6m97 ckdsp
8 Apr 21
Crinetics Pharmaceuticals Announces Pricing of Public Offering of Common Stock
4:09pm
424B5
4jfr8 38aywz2gt8cpy0
8 Apr 21
Prospectus supplement for primary offering
4:07pm
8-K
EX-99.1
2uuea4
30 Mar 21
Crinetics Pharmaceuticals Announces 2021 Clinical Plans and Reports Fourth Quarter and Full Year 2020 Financial Results
5:05pm
DEFA14A
p110o9njm
28 Apr 20
Additional proxy soliciting materials
4:10pm
424B5
4ctng0tbn 4u8e
15 Apr 20
Prospectus supplement for primary offering
4:16pm